Arcus Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 89.9% | 89.9% | — |
| FY2017 | 73.4% | 73.4% | -27.9% |
| FY2018 | -21.1% | -21.1% | -18.0% |
| FY2019 | -51.7% | -51.7% | -41.7% |
| FY2020 | -24.5% | -24.5% | -15.9% |
| FY2021 | 6.3% | 6.3% | 3.3% |
| FY2022 | -40.6% | -40.6% | -19.9% |
| FY2023 | -66.5% | -66.5% | -28.0% |
| FY2024 | -58.4% | -53.1% | -24.6% |
| FY2025 | -55.9% | -48.4% | -31.0% |